Möhn, N., Narten, E., Duzzi, L., Thomas, J., Grote-Levi, L., Beutel, G., . . . Skripuletz, T. Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMöhn, Nora, et al. Low Triglyceride Levels Are Associated with Increased Risk of Immune-related Adverse Events in Patients Receiving Immune Checkpoint Inhibitors. Taylor & Francis Group.
MLA (9th ed.) CitationMöhn, Nora, et al. Low Triglyceride Levels Are Associated with Increased Risk of Immune-related Adverse Events in Patients Receiving Immune Checkpoint Inhibitors. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.